Skip to content
Screener

Aldeyra Therapeutics ALDX Q4 2025 Annual earnings

Reported February 27, 2026 · After market close

EPS-$0.11Beat by $0.03
Revenue estimate$4.8M
EPS estimate-$0.14

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$2.5M
EPS estimate-$0.11

FAQ

When did Aldeyra Therapeutics report Q4 2025 earnings?
Aldeyra Therapeutics (ALDX) reported Q4 2025 earnings on February 27, 2026 after market close.
What were Aldeyra Therapeutics's Q4 2025 revenue and EPS?
Aldeyra Therapeutics reported eps of $-0.11 for Q4 2025.
Did Aldeyra Therapeutics beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.14 by $0.03.
How did Aldeyra Therapeutics's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 59.3% from $-0.27.
Where can I find Aldeyra Therapeutics's Q4 2025 SEC filings?
You can read the 10-K periodic report (0001193125-26-083012) directly on SEC EDGAR. The filing index links above go to sec.gov.